Showing results (281-290 of 760) with videos related to

Sort By:
Pageof 76
Cancer Research|January 9, 2003
Nuclear factor-kappaB p65 mediates tumor necrosis factor alpha-induced nuclear translocation of telomerase reverse transcriptase proteinMasaharu Akiyama, Teru Hideshima, Toshiaki Hayashi, et al.
Cancer|February 14, 2006
Extended follow-up of a phase II trial in relapsed, refractory multiple myeloma:: final time-to-event results from the SUMMIT trialPaul G Richardson, Bart Barlogie, James Berenson, et al.
Seminars in Hematology|April 25, 2009
Emerging treatments for multiple myeloma: beyond immunomodulatory drugs and bortezomibConstantine S Mitsiades, Teru Hideshima, Dharminder Chauhan, et al.
The Journal of Chemical Physics|October 5, 2013
Phase transitions in human IgG solutionsYing Wang, Aleksey Lomakin, Ramil F Latypov, et al.
Cancer Research|July 5, 2002
Cytokines modulate telomerase activity in a human multiple myeloma cell lineMasaharu Akiyama, Teru Hideshima, Toshiaki Hayashi, et al.
Seminars in Oncology|April 30, 2003
Expression of serotherapy target antigens in Waldenstrom's macroglobulinemia: therapeutic applications and considerationsSteven P Treon, Abigail Kelliher, Beverly Keele, et al.
The Journal of Biological Chemistry|March 11, 2004
Critical role for hematopoietic cell kinase (Hck)-mediated phosphorylation of Gab1 and Gab2 docking proteins in interleukin 6-induced proliferation and survival of multiple myeloma cellsKlaus Podar, Gustavo Mostoslavsky, Martin Sattler, et al.
Cancer Research|October 16, 2003
Effects of oligonucleotide N3'-->P5' thio-phosphoramidate (GRN163) targeting telomerase RNA in human multiple myeloma cellsMasaharu Akiyama, Teru Hideshima, Masood A Shammas, et al.
British Journal of Haematology|July 8, 2011
Managing multiple myeloma: the emerging role of novel therapies and adapting combination treatment for higher risk settingsPaul G Richardson, Jacob Laubach, Constantine S Mitsiades, et al.
Blood|January 19, 2006
Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cellsTeru Hideshima, Laurence Catley, Hiroshi Yasui, et al.
Pageof 76